313 related articles for article (PubMed ID: 30554155)
1. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.
Landon-Cardinal O; Allenbach Y; Soulages A; Rigolet A; Hervier B; Champtiaux N; Monzani Q; Solé G; Benveniste O
J Rheumatol; 2019 Jun; 46(6):623-627. PubMed ID: 30554155
[TBL] [Abstract][Full Text] [Related]
2. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
[TBL] [Abstract][Full Text] [Related]
3. Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab.
Zhang W; Prince HM; Reardon K
BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791994
[TBL] [Abstract][Full Text] [Related]
4. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
5. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
6. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
7. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
10. Statins and myositis: the role of anti-HMGCR antibodies.
Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
[TBL] [Abstract][Full Text] [Related]
11. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
13. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
14. Favorable Response in Statin-Naive Paraneoplastic Anti-HMGCR Antibody-Associated Myopathy to Single Dose of Rituximab and Persistent Remission With Management of Underlying Lung Cancer.
Waheed W; Jones C; Gentchos G; DeWitt J; Tandan R
J Clin Neuromuscul Dis; 2019 Sep; 21(1):14-24. PubMed ID: 31453850
[TBL] [Abstract][Full Text] [Related]
15. [Immune-Mediated Necrotizing Myopathy].
Uruha A
Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
[TBL] [Abstract][Full Text] [Related]
16. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy.
Suárez B; Jofré J; Lozano-Arango A; Ortega X; Diaz J; Calcagno G; Bevilacqua JA; Castiglioni C
Neuromuscul Disord; 2020 Jun; 30(6):503-509. PubMed ID: 32518057
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
20. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
